XBIT – XBiotech Inc.
XBIT
$2.88Name : XBiotech Inc.
Sector : Healthcare
Industry: Biotechnology
Mark. Cap: $87,804,576.00
EPSttm : -1.26
XBiotech Inc.
$2.88
Float Short %
4.61
Margin Of Safety %
Put/Call OI Ratio
0.06
EPS Next Q Diff
EPS Last/This Y
EPS This/Next Y
Price
2.9
Target Price
28
Analyst Recom
3
Performance Q
-10.56
Relative Volume
0.71
Beta
1
Ticker: XBIT
22 items
«
‹
of 1
›
»
Date | Symbol | Last | P/C OI | P/C Vol | Total OI |
---|---|---|---|---|---|
2025-04-15 | XBIT | 3.19 | 0.10 | 3.33 | 86 |
2025-04-16 | XBIT | 2.96 | 0.74 | 999.99 | 136 |
2025-04-17 | XBIT | 2.93 | 0.74 | 999.99 | 136 |
2025-04-18 | XBIT | 2.94 | 0.74 | 999.99 | 136 |
2025-04-21 | XBIT | 2.97 | 0.74 | 999.99 | 136 |
2025-04-22 | XBIT | 3.12 | 0.74 | 999.99 | 136 |
2025-04-23 | XBIT | 3.11 | 0.74 | 999.99 | 136 |
2025-04-24 | XBIT | 2.96 | N/A | N/A | 0 |
2025-04-25 | XBIT | 2.91 | N/A | N/A | N/A |
2025-04-28 | XBIT | 2.88 | N/A | N/A | N/A |
2025-04-29 | XBIT | 2.87 | N/A | N/A | 0 |
2025-04-30 | XBIT | 3.08 | N/A | N/A | 0 |
2025-05-01 | XBIT | 2.94 | N/A | N/A | 0 |
2025-05-02 | XBIT | 2.93 | N/A | N/A | 0 |
2025-05-05 | XBIT | 2.85 | N/A | N/A | 0 |
2025-05-06 | XBIT | 2.77 | N/A | N/A | 0 |
2025-05-07 | XBIT | 2.76 | N/A | N/A | 0 |
2025-05-08 | XBIT | 2.87 | N/A | N/A | 0 |
2025-05-09 | XBIT | 2.84 | N/A | N/A | 0 |
2025-05-12 | XBIT | 2.9 | N/A | N/A | 0 |
2025-05-13 | XBIT | 2.96 | 0.06 | 0.00 | 67 |
2025-05-14 | XBIT | 2.89 | 0.06 | 0.00 | 73 |
Date | Symbol | Last | P/C OI | P/C Vol | Total OI |
22 items
«
‹
Current Page1 of 1
›
»
22 items
«
‹
of 1
›
»
Date | Ticker | Price | Current Quarter Growth Estimate | EBIT Estimation | Average EPS Estimate Current Year |
---|---|---|---|---|---|
2025-04-15 | XBIT | 3.18 | - | - | - |
2025-04-16 | XBIT | 2.97 | - | - | - |
2025-04-17 | XBIT | 2.94 | - | - | - |
2025-04-18 | XBIT | 2.94 | - | - | - |
2025-04-21 | XBIT | 2.97 | - | - | - |
2025-04-22 | XBIT | 3.12 | - | - | - |
2025-04-23 | XBIT | 3.16 | - | - | - |
2025-04-24 | XBIT | 2.96 | - | - | - |
2025-04-25 | XBIT | 2.91 | - | - | - |
2025-04-28 | XBIT | 2.88 | - | - | - |
2025-04-29 | XBIT | 2.87 | - | - | - |
2025-04-30 | XBIT | 3.04 | - | - | - |
2025-05-01 | XBIT | 2.93 | - | - | - |
2025-05-02 | XBIT | 2.92 | - | - | - |
2025-05-05 | XBIT | 2.85 | - | - | - |
2025-05-06 | XBIT | 2.77 | - | - | - |
2025-05-07 | XBIT | 2.79 | - | - | - |
2025-05-08 | XBIT | 2.83 | - | - | - |
2025-05-09 | XBIT | 2.84 | - | - | - |
2025-05-12 | XBIT | 2.91 | - | - | - |
2025-05-13 | XBIT | 2.98 | - | - | - |
2025-05-14 | XBIT | 2.90 | - | - | - |
Date | Ticker | Price | Current Quarter Growth Estimate | EBIT Estimation | Average EPS Estimate Current Year |
22 items
«
‹
Current Page1 of 1
›
»
22 items
«
‹
of 1
›
»
Date | Ticker | Insider Transactions | Institutional Transactions | Float Short |
---|---|---|---|---|
2025-04-15 | XBIT | 0.00 | -2.99 | 3.97 |
2025-04-16 | XBIT | 0.00 | -2.99 | 3.97 |
2025-04-17 | XBIT | 0.00 | -2.99 | 3.97 |
2025-04-18 | XBIT | 0.00 | -2.99 | 3.97 |
2025-04-21 | XBIT | 0.00 | -2.96 | 3.97 |
2025-04-22 | XBIT | 0.00 | -2.96 | 3.97 |
2025-04-23 | XBIT | 0.00 | -2.96 | 3.97 |
2025-04-24 | XBIT | 0.00 | -2.96 | 3.97 |
2025-04-25 | XBIT | 0.00 | -2.96 | 3.97 |
2025-04-28 | XBIT | 0.00 | -2.96 | 3.58 |
2025-04-29 | XBIT | 0.00 | -2.96 | 3.58 |
2025-04-30 | XBIT | 0.00 | -2.96 | 3.58 |
2025-05-01 | XBIT | 0.00 | -2.96 | 3.58 |
2025-05-02 | XBIT | 0.00 | -2.96 | 3.58 |
2025-05-05 | XBIT | 0.00 | -3.29 | 3.58 |
2025-05-06 | XBIT | 0.00 | -3.29 | 3.58 |
2025-05-07 | XBIT | 0.00 | -3.29 | 3.58 |
2025-05-08 | XBIT | 0.00 | -3.29 | 3.58 |
2025-05-09 | XBIT | 0.00 | -3.29 | 3.58 |
2025-05-12 | XBIT | 0.00 | -4.41 | 4.61 |
2025-05-13 | XBIT | 0.00 | -4.41 | 4.61 |
2025-05-14 | XBIT | 0.00 | -4.41 | 4.61 |
Date | Ticker | Insider Transactions | Institutional Transactions | Float Short |
22 items
«
‹
Current Page1 of 1
›
»
Last Quarter Act. EPS
Avg. EPS Est. Current Quarter
Avg. EPS Est. Next Quarter
Insider Transactions
Institutional Transactions
-4.41
Beta
1
Average Sales Estimate Current Quarter
Average Sales Estimate Next Quarter
Fair Value
Quality Score
19
Growth Score
Sentiment Score
77
Actual DrawDown %
86.5
Max Drawdown 5-Year %
-84.8
Target Price
28
P/E
Forward P/E
PEG
P/S
P/B
0.48
P/Free Cash Flow
EPS
-1.26
Average EPS Est. Cur. Y
EPS Next Y. (Est.)
Target Price Estimates Raised
Target Price Estimates Lowered
Profit Margin
Relative Volume
0.71
Return on Equity vs Sector %
-44.8
Return on Equity vs Industry %
-28
EPS 1 7Days Diff
EPS 1 30Days Diff
EBIT Estimation
Sector: Healthcare
Industry: Biotechnology
Employees: 92
XBiotech Inc., a biopharmaceutical company, discovers, develops, and commercializes true human monoclonal antibodies for treating various diseases. It develops a pipeline of product candidates targeting inflammatory and infectious diseases. The company is also developing interleukin-1 alpha therapies to various medical conditions, such as cancer, stroke, heart attack, or arthritis; and mediates tissue breakdown, angiogenesis, the formation of blood clots, malaise, muscle wasting, and general inflammation. The company was incorporated in 2005 and is headquartered in Austin, Texas.
stock quote shares XBIT – XBiotech Inc. Stock Price stock today
news today XBIT – XBiotech Inc. stock forecast ,stock prediction 2023 2024 2025
marketwatch XBIT – XBiotech Inc. yahoo finance google finance
stock history XBIT – XBiotech Inc. invest stock market
stock prices XBIT premarket after hours
ticker XBIT fair value insiders trading